Alumni Ventures

www.av.vc/funds/healthtech

VCMatch tracks Alumni Ventures as an investor focused on Digital Health, Biotech, and Medtech companies, Pre-Seed and Seed rounds, and United States, North America, and Europe markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage

Focus Areas

Digital Health, Biotech, Medtech

Geography

United States, North America, and Europe

Investment Thesis

Alumni Ventures (AV) pursues a diversified, access-driven venture strategy: they operate both annual diversified funds and selective deal-by-deal syndicates to give accredited individuals exposure to high-quality, venture-backed companies. AV emphasizes co-investing alongside established lead VCs, broad diversification across stage/sector/geography, rigorous shared due diligence, and reserving capital for follow-ons (roughly 20–25%) to capture upside in the most promising portfolio companies.

Is Alumni Ventures right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Alumni Ventures is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Digital Health, Biotech, Medtech, and AI/ML, especially across United States, North America, and Europe.

Focus statement

AV focuses on healthtech & life sciences ("bold healthcare companies building at the intersection of infrastructure, care delivery, and frontier science") while also running sector funds in AI, deep tech, and other thematic areas; they invest across stages and geographies and routinely co-invest with top-tier lead VCs.

Value Add

Hybrid product: "A private community, investing syndicate and fund" — combination of annual funds and deal-by-deal syndications that individual accredited investors can join.
Co-investment model: explicit emphasis on "Co-Invest With Elite VCs" and participating alongside firms like Andreessen Horowitz, Sequoia, Y Combinator, Khosla, etc.
Democratized access: positions itself as "America's Largest Venture Firm for Individuals" and offers low minimums, deal transparency, and access to due diligence materials and video briefs.
Scale & deal flow: "$1.4B+ deployed across 1,400+ venture-backed companies" and sourcing 50–75 opportunities per quarter via a 40-person nationwide team and a large alumni network.
Process features: standardized deployment cadence (funds of ~20–30 investments deployed over ~12–18 months), and a stated follow-on reserve (~20–25%).
Community & proprietary flow: large investor/community base ("11,000 accredited investors and an 850,000-strong alumni & entrepreneur community") used to generate dealflow, talent pipelines, and follow-on capital.
Transparency & diligence sharing: members get "Due Diligence and Investment Memos provided," access to a diligence portal, and "Why We Are Investing" video briefs.